EMPERY ASSET MANAGEMENT, LP/PHARMATHENE, INC.

Company

Altimmune, Inc.

Filed

April 19, 2010

Accession Number

0000902664-10-002434

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →